The Prolyl Hydroxylase Inhibitor BIQ/FG-2216 Stabilises HIF-1 alpha and Upregulates VEGF in vitro: A Potential Strategy For Difficult CTO Lesions in Patients.

অনুরূপ উপাদানগুলি

• 74 Pro-Angiogenic Effects of the Prolyl-hydroxylase Inhibitor FG-2216/BIQ: Therapeutic Angiogenesis for the Treatment of Chronic Total Occlusions.
  অনুযায়ী: Barnett, G, অন্যান্য
  প্রকাশিত: (2014)
• Pro-angiogenic effects of proly-hydroxylase inhibitor FG-2216 and potential for use in a novel strategy of therapeutic angiogenesis for difficult cases of coronary total occlusion
  অনুযায়ী: Barnett, G, অন্যান্য
  প্রকাশিত: (2014)
• Enhanced Endothelial Tubule Formation in Response to Proly-Hydroxylase Inhibitor FG-2216: A Step Towards Therapeutic Angiogenesis in Chronic Total Occlusions
  অনুযায়ী: Barnett, G, অন্যান্য
  প্রকাশিত: (2012)
• Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
  অনুযায়ী: Flashman, E, অন্যান্য
  প্রকাশিত: (2010)
• Regulation of HIF: prolyl hydroxylases.
  অনুযায়ী: Stolze, I, অন্যান্য
  প্রকাশিত: (2006)